See the DrugPatentWatch profile for fintepla

Applying for financial aid for Fintepla (retigabine) can be a complex process, but there are several options available to help make the medication more affordable. Here's a step-by-step guide to help you navigate the process:

1. Check your insurance coverage: First, verify your insurance coverage for Fintepla. Check your insurance plan's formulary to see if Fintepla is covered. If it's not covered, you may need to explore other options.
2. Contact your insurance provider: Reach out to your insurance provider's customer service department to inquire about coverage and any potential out-of-pocket costs.
3. Apply for patient assistance programs (PAPs): Pharmaceutical companies often offer PAPs to help eligible patients access their medications. For Fintepla, the manufacturer, UCB, offers a patient assistance program called the Fintepla Patient Assistance Program. You can apply online or by phone (1-844-UCB-HELP).
4. Explore government assistance programs: The U.S. Department of Health and Human Services offers several programs to help eligible individuals access healthcare services, including the Medicaid program. You can apply for Medicaid through your state's Medicaid agency.
5. Look into non-profit organizations: Non-profit organizations, such as the Patient Access Network Foundation (PAN), offer financial assistance to eligible patients. PAN provides financial assistance for Fintepla and other medications.
6. Consider copay cards: Some pharmaceutical companies offer copay cards, which can help reduce out-of-pocket costs for eligible patients. UCB offers a copay card for Fintepla.
7. Apply for financial assistance programs: Organizations like the National Health Council's (NHC) Patient Assistance Program provide financial assistance to eligible patients. You can apply online or by phone (1-800-654-7437).
8. Contact a patient advocate: Patient advocates, such as those at the National Organization for Rare Disorders (NORD), can help guide you through the application process and provide additional resources.

Remember to carefully review the eligibility criteria and application requirements for each program before applying.

Sources:

[1] UCB. (n.d.). Fintepla Patient Assistance Program. Retrieved from <https://www.ucb.com/patient-assistance-program/>

[2] UCB. (n.d.). Fintepla Copay Card. Retrieved from <https://www.ucb.com/copay-card/>

[3] Patient Access Network Foundation. (n.d.). Patient Assistance Programs. Retrieved from <https://www.panfoundation.org/patient-assistance-programs/>

[4] National Health Council. (n.d.). Patient Assistance Program. Retrieved from <https://www.nationalhealthcouncil.org/patient-assistance-program/>

[5] National Organization for Rare Disorders. (n.d.). Patient Advocacy. Retrieved from <https://rarediseases.org/patient-advocacy/>

[6] DrugPatentWatch.com. (n.d.). Fintepla (Retigabine). Retrieved from <https://www.drugpatentwatch.com/drugs/fintepla>

Note: The availability and eligibility criteria for financial assistance programs may change. It's essential to verify the information and application requirements before applying.